YAP1 and hepatocellular carcinoma: The transcription factors YAP/TAZ were recognized as crucial catalysts of Sorafenib resistance in HCC through the prevention of Sorafenib-induced ferroptosis in this investigation, which utilized a combination of shRNA-mediated synthetic lethality screening and transcriptomic analysis.